Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
IPH.PA Stock Summary
Top 10 Correlated ETFs
IPH.PA
In the News
IPH.PA Financial details
Company Rating
Strong Buy
Market Cap
175.02M
Income
-71.12M
Revenue
80.31M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
191
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-2.07
Forward P/E
3.53
PEG
0.72
P/S
4.18
P/B
3.79
P/C
-
P/FCF
-10.24
Quick Ratio
3.38
Current Ratio
3.38
Debt / Equity
0.77
LT Debt / Equity
0.6
-
-
EPS (TTM)
-0.89
EPS next Y
0.62
EPS next Q
-
EPS this Y
-92.47%
EPS next Y
-169.21%
EPS next 5Y
-115.76%
EPS last 5Y
-21.21%
Revenue last 5Y
-5.53%
Revenue Q/Q
-53.15%
EPS Q/Q
-660.75%
-
-
-
-
SMA20
-5.6%
SMA50
-12.75%
SMA100
-5.19%
Inst Own
0.2%
Inst Trans
0%
ROA
-48%
ROE
-123%
ROC
-0.07%
Gross Margin
100%
Oper. Margin
-23%
Profit Margin
-200%
Payout
-
Shs Outstand
80.84M
Shs Float
55.37M
-
-
-
-
Target Price
-
52W Range
2.11-3.345
52W High
-27%
52W Low
+9.5%
RSI
43.38
Rel Volume
0.44
Avg Volume
85.47K
Volume
37.83K
Perf Week
-1.35%
Perf Month
-5.19%
Perf Quarter
-3.95%
Perf Half Y
-12.75%
-
-
-
-
Beta
0.659
-
-
Volatility
0.01%, 0.07%
Prev Close
0%
Price
2.19
Change
0%
IPH.PA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.03 | 0.72 | 0.15 | 0.63 | 0.65 | |
Net income per share | -0.31 | -0.9 | -0.74 | -1.25 | -0.09 | |
Operating cash flow per share | 0.52 | -0.66 | -0.73 | -0.24 | -0.4 | |
Free cash flow per share | -0.46 | -0.8 | -0.75 | -0.26 | -0.43 | |
Cash per share | 3.27 | 1.92 | 1.51 | 1.28 | 1.15 | |
Book value per share | 3.25 | 1.98 | 1.35 | 0.68 | 0.65 | |
Tangible book value per share | 1.8 | 1.39 | 0.8 | 0.66 | 0.65 | |
Share holders equity per share | 3.25 | 1.98 | 1.35 | 0.68 | 0.65 | |
Interest debt per share | 0.28 | 0.33 | 0.61 | 0.6 | 0.52 | |
Market cap | 398.77M | 273.27M | 353.81M | 261.27M | 210.79M | |
Enterprise value | 214.61M | 155.57M | 294.3M | 219.3M | 180.07M | |
P/E ratio | -19.02 | -3.86 | -5.98 | -2.64 | -27.85 | |
Price to sales ratio | 5.78 | 4.81 | 29.21 | 5.26 | 4.06 | |
POCF ratio | 11.42 | -5.27 | -6.05 | -13.64 | -6.47 | |
PFCF ratio | -13.08 | -4.33 | -5.92 | -12.89 | -6.04 | |
P/B Ratio | 1.83 | 1.75 | 3.29 | 4.82 | 4.06 | |
PTB ratio | 1.83 | 1.75 | 3.29 | 4.82 | 4.06 | |
EV to sales | 3.11 | 2.74 | 24.3 | 4.42 | 3.47 | |
Enterprise value over EBITDA | -24.16 | 3.61 | -7.98 | 6.5 | -10.4 | |
EV to operating cash flow | 6.15 | -3 | -5.03 | -11.45 | -5.53 | |
EV to free cash flow | -7.04 | -2.47 | -4.92 | -10.82 | -5.16 | |
Earnings yield | -0.05 | -0.26 | -0.17 | -0.38 | -0.04 | |
Free cash flow yield | -0.08 | -0.23 | -0.17 | -0.08 | -0.17 | |
Debt to equity | 0.09 | 0.12 | 0.41 | 0.78 | 0.77 | |
Debt to assets | 0.05 | 0.06 | 0.17 | 0.2 | 0.22 | |
Net debt to EBITDA | 20.73 | -2.73 | 1.61 | -1.24 | 1.77 | |
Current ratio | 1.95 | 3.71 | 1.73 | 3.38 | 3.73 | |
Interest coverage | -132.61 | -2.02 | -11.97 | -2.19 | -12.21 | |
Income quality | -1.68 | 0.81 | 1.11 | 0.33 | 4.3 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.59 | 0.55 | 1.32 | 0.29 | 0 | |
Research and developement to revenue | 0.02 | 1.03 | 3.88 | 1.04 | 1.08 | |
Intangibles to total assets | 0.24 | 0.15 | 0.17 | 0.01 | 0 | |
Capex to operating cash flow | -1.87 | 0.22 | 0.02 | 0.06 | 0.07 | |
Capex to revenue | -0.95 | -0.2 | -0.11 | -0.02 | -0.05 | |
Capex to depreciation | -3.96 | -0.2 | -0.29 | -0.02 | -0.46 | |
Stock based compensation to revenue | 0.06 | 0.04 | 0.22 | 0.09 | 0 | |
Graham number | 4.79 | 6.31 | 4.75 | 4.38 | 1.17 | |
ROIC | -0.11 | -0.08 | -0.4 | -0.2 | -0.11 | |
Return on tangible assets | -0.07 | -0.27 | -0.26 | -0.48 | -0.04 | |
Graham Net | 0.71 | 0.21 | -0.36 | -0.3 | 0.02 | |
Working capital | 115.78M | 126.64M | 58.37M | 98.49M | 108.38M | |
Tangible asset value | 120.45M | 109.69M | 63.25M | 52.6M | 51.49M | |
Net current asset value | 53.66M | 21.88M | -21.8M | -13.88M | 15.72M | |
Invested capital | 0.09 | 0.12 | 0.41 | 0.78 | 0.77 | |
Average receivables | 79.89M | 17.42M | 20.06M | 28.38M | 46.95M | |
Average payables | 34.81M | 28.74M | 29.06M | 24.74M | 18.96M | |
Average inventory | 2.8M | 2.8M | -2.47M | -2.47M | -1000 | |
Days sales outstanding | 69.54 | 139.33 | 555.09 | 281.96 | 390.71 | |
Days payables outstanding | 225.8 | 3.54K | 221.88 | 147.74 | 0 | |
Days of inventory on hand | 45.26 | 0 | -38.41 | -0.01 | 0 | |
Receivables turnover | 5.25 | 2.62 | 0.66 | 1.29 | 0.93 | |
Payables turnover | 1.62 | 0.1 | 1.65 | 2.47 | 0 | |
Inventory turnover | 8.06 | 3.04M | -9.5 | -25.83K | 0 | |
ROE | -0.1 | -0.45 | -0.55 | -1.83 | -0.15 | |
Capex per share | -0.98 | -0.14 | -0.02 | -0.01 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.08 | 0.1 | 0.23 | 0.44 | 0 | |
Net income per share | -0.41 | -0.8 | 0.01 | 0.02 | 0 | |
Operating cash flow per share | -0.13 | -0.25 | -0.07 | -0.14 | 0 | |
Free cash flow per share | -0.13 | -0.26 | -0.07 | -0.15 | 0 | |
Cash per share | 1.28 | 1.27 | 1.03 | 1.11 | 0 | |
Book value per share | 0.68 | 0.68 | 0.67 | 0.72 | 0 | |
Tangible book value per share | 0.66 | 0.66 | 0.66 | 0.71 | 0 | |
Share holders equity per share | 0.68 | 0.68 | 0.67 | 0.72 | 0 | |
Interest debt per share | 0.49 | 0.53 | 0.41 | 0.51 | 0 | |
Market cap | 167.23M | 263.84M | 230.56M | 231.32M | 0 | |
Enterprise value | 83.01M | 221.86M | 159.14M | 200.57M | -30.71M | |
P/E ratio | -1.3 | -1.02 | 67.1 | 33.66 | 0 | |
Price to sales ratio | 27.68 | 31.75 | 11.47 | 6.54 | 0 | |
POCF ratio | -16.42 | -13.06 | -40.22 | -20.18 | 0 | |
PFCF ratio | -16.33 | -12.62 | -39.16 | -19.64 | 0 | |
P/B Ratio | 3.09 | 4.87 | 3.98 | 4 | 0 | |
PTB ratio | 3.09 | 4.87 | 3.98 | 4 | 0 | |
EV to sales | 13.74 | 26.7 | 7.92 | 5.67 | -1.85 | |
Enterprise value over EBITDA | -7.54 | -8.4 | 112.95 | -124.73 | 1.95 | |
EV to operating cash flow | -8.15 | -10.98 | -27.76 | -17.49 | 1.46 | |
EV to free cash flow | -8.1 | -10.61 | -27.03 | -17.03 | 1.33 | |
Earnings yield | -0.19 | -0.24 | 0 | 0.01 | 0 | |
Free cash flow yield | -0.06 | -0.08 | -0.03 | -0.05 | 0 | |
Debt to equity | 0.72 | 0.78 | 0.6 | 0.7 | 0.77 | |
Debt to assets | 0.19 | 0.2 | 0.17 | 0.2 | 0.22 | |
Net debt to EBITDA | 7.65 | 1.59 | -50.68 | 19.13 | 1.95 | |
Current ratio | 3.38 | 3.38 | 3.84 | 3.84 | 3.73 | |
Interest coverage | 0 | -306.43 | 0 | -16.21 | -11.35 | |
Income quality | 0.32 | 0.31 | -6.67 | -6.67 | 2.27 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.84 | 0.61 | 0.22 | 0.13 | 0 | |
Research and developement to revenue | 2.21 | 3.03 | 0.78 | 0.8 | 1.48 | |
Intangibles to total assets | 0.01 | 0.01 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.01 | 0.03 | 0.03 | 0.03 | 0.1 | |
Capex to revenue | -0.01 | -0.08 | -0.01 | -0.01 | -0.12 | |
Capex to depreciation | -0.05 | -0.29 | -0.08 | -0.09 | -1.41 | |
Stock based compensation to revenue | 0.14 | 0.1 | 0.03 | 0.02 | 0 | |
Graham number | 2.5 | 3.49 | 0.39 | 0.59 | 0 | |
ROIC | -0.13 | -0.28 | 0 | 0.03 | -0.12 | |
Return on tangible assets | -0.16 | -0.31 | 0 | 0.01 | -0.05 | |
Graham Net | -0.63 | -0.29 | -0.58 | -0.17 | 0 | |
Working capital | 98.49M | 98.49M | 106.79M | 106.79M | 108.38M | |
Tangible asset value | 52.6M | 52.6M | 56.96M | 56.96M | 51.49M | |
Net current asset value | -13.88M | -13.88M | 3.27M | 3.27M | 15.72M | |
Invested capital | 0.72 | 0.78 | 0.6 | 0.7 | 0.77 | |
Average receivables | 22.46M | 20.71M | 20.64M | 29.25M | 0 | |
Average payables | 13.29M | 17.28M | 15.39M | 14.43M | 0 | |
Average inventory | 0.5 | -999.5 | -1000 | -3.24M | 0 | |
Days sales outstanding | 45.88 | 415.35 | 13.14 | 141.49 | 301.99 | |
Days payables outstanding | 92.04 | 140.94 | 56.47 | 108.68 | 0 | |
Days of inventory on hand | 0 | -0.01 | 0 | -37.05 | 0 | |
Receivables turnover | 1.96 | 0.22 | 6.85 | 0.64 | 0.3 | |
Payables turnover | 0.98 | 0.64 | 1.59 | 0.83 | 0 | |
Inventory turnover | 13.35M | -6.68K | 0 | -2.43 | 0 | |
ROE | -0.59 | -1.19 | 0.01 | 0.03 | -0.18 | |
Capex per share | 0 | -0.01 | 0 | 0 | 0 |
IPH.PA Frequently Asked Questions
What is Innate Pharma S.A. stock symbol ?
Innate Pharma S.A. is a FR stock and trading under the symbol IPH.PA
What is Innate Pharma S.A. stock quote today ?
Innate Pharma S.A. stock price is $2.19 today.
Is Innate Pharma S.A. stock public?
Yes, Innate Pharma S.A. is a publicly traded company.